BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30961512)

  • 1. Novel Thiazine Substituted 9-Anilinoacridines: Synthesis, Antitumour Activity and Structure Activity Relationships.
    Kalirajan R; Gaurav K; Pandiselvi A; Gowramma B; Sankar S
    Anticancer Agents Med Chem; 2019; 19(11):1350-1358. PubMed ID: 30961512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors.
    Kalirajan R; Kulshrestha V; Sankar S; Jubie S
    Eur J Med Chem; 2012 Oct; 56():217-24. PubMed ID: 22982526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings.
    Chen CH; Lin YW; Zhang X; Chou TC; Tsai TJ; Kapuriya N; Kakadiya R; Su TL
    Eur J Med Chem; 2009 Jul; 44(7):3056-9. PubMed ID: 18752869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
    Kapuriya N; Kapuriya K; Zhang X; Chou TC; Kakadiya R; Wu YT; Tsai TH; Chen YT; Lee TC; Shah A; Naliapara Y; Su TL
    Bioorg Med Chem; 2008 May; 16(10):5413-23. PubMed ID: 18450456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
    Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
    Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
    Bacherikov VA; Chou TC; Dong HJ; Zhang X; Chen CH; Lin YW; Tsai TJ; Lee RZ; Liu LF; Su TL
    Bioorg Med Chem; 2005 Jun; 13(12):3993-4006. PubMed ID: 15911312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of sulfur-containing 9-anilinoacridines.
    Chen KM; Sun YW; Tang YW; Sun ZY; Kwon CH
    Mol Pharm; 2005; 2(2):118-28. PubMed ID: 15804186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of angularly condensed diquinothiazines as potential anticancer agents.
    Jeleń M; Pluta K; Latocha M; Morak-Młodawska B; Suwińska K; Kuśmierz D
    Bioorg Chem; 2019 Jun; 87():810-820. PubMed ID: 30981160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.
    Su TL; Chou TC; Kim JY; Huang JT; Ciszewska G; Ren WY; Otter GM; Sirotnak FM; Watanabe KA
    J Med Chem; 1995 Aug; 38(17):3226-35. PubMed ID: 7650675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationships (QSAR) for 9-anilinoacridines: a comparative analysis.
    Gao H; Denny WA; Garg R; Hansch C
    Chem Biol Interact; 1998 Nov; 116(3):157-80. PubMed ID: 9920460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance.
    Baguley BC; Holdaway KM; Fray LM
    J Natl Cancer Inst; 1990 Mar; 82(5):398-402. PubMed ID: 2154584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.
    Searcey M; McClean S; Madden B; McGown AT; Wakelin LP
    Anticancer Drug Des; 1998 Dec; 13(8):837-55. PubMed ID: 10335263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma.
    Rewcastle GW; Denny WA; Wilson WR; Baguley BC
    Anticancer Drug Des; 1986 Nov; 1(3):215-22. PubMed ID: 3450294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and In Vitro Antiproliferative Activity of Novel Phenyl Ring-Substituted 5-Alkyl-12(H)-quino[3,4-b][1,4]benzothiazine Derivatives.
    Zięba A; Latocha M; Sochanik A; Nycz A; Kuśmierz D
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of 2,3-diarylated 2H-benzo[e][1,2]thiazine 1,1-dioxides and their 3,4-dihydro derivatives, and assessment of their inhibitory activity against MCF-7 breast cancer cells.
    Shan YY; Zhang CM; Tang LQ; Liu ZP; Bearss NR; Sarver JG; Luniwal A; Erhardt PW
    Med Chem; 2011 Nov; 7(6):561-71. PubMed ID: 22313296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of cyclopenta(hepta)[b]thiophene and fused cyclohepta[b]thiophene analogs.
    Abdel-Rahman SA; El-Gohary NS; El-Bendary ER; El-Ashry SM; Shaaban MI
    Eur J Med Chem; 2017 Nov; 140():200-211. PubMed ID: 28926764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amsacrine analogues with extended chromophores: DNA binding and anti-tumour activity.
    Denny WA; Baguley BC
    Anticancer Drug Des; 1987 Aug; 2(1):61-70. PubMed ID: 3449085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Anticancer Evaluation of Sulfur Containing 9-anilinoacridines.
    Gupta P; Kumar RV; Kwon CH; Chen ZS
    Recent Pat Anticancer Drug Discov; 2022; 17(1):102-119. PubMed ID: 34323200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
    Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
    Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.